lixisenatide glp 1 Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes Aldrich Lixisenatide Sigma-Aldrich Lixisenatide, CAS 320367-13-3, ≥95%
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5



























